Performance of claims-based Alzheimer’s disease and related dementias algorithms in Medicare Advantage and fee-for-service populations
- 18 September 2026
- journal article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (11)
Abstract
Background: Evidence comparing the performance of claims-based dementia algorithms across Medicare Advantage (MA) and fee-for-service (FFS) populations remains limited. We evaluated the validity of 2 claims-based algorithms across MA and FFS populations. Methods: We used nationally representative, linked National Health and Aging Trends Study (NHATS)-Medicare data to identify community-dwelling participants with continuous enrollment in MA or FFS during Round 7 (2017; n = 5018), Round 9 (2019; n = 4018), and Round 11 (2021-2022; n = 3086). Using NHATS probable dementia as reference standard, we validated the Bynum-Standard and Chronic Condition Warehouse (CCW) dementia algorithms across 3-time points. Results: Overall, both algorithms demonstrated comparable performance in MA and FFS populations, with high specificity (>97.9%) and negative predictive value (>92.9%). The Bynum algorithm showed similar sensitivity between MA and FFS in Rounds 7 (30.2% vs 29.1%) and 11 (25.6% vs 23.9%), but lower sensitivity in MA for Round 9 (25.0% vs 36.4%). Positive predictive value (PPV) was similar between MA (62.7%-70.6%) and FFS (62.1%-70.4%) across all rounds. The CCW algorithm demonstrated greater MA-FFS differences, with lower sensitivity in MA for Rounds 9 (30.8% vs 46.9%) and 11 (35.0% vs 49.3%) and similar sensitivity for Round 7 (40.4% vs 42.2%). PPV varied across rounds in both MA and FFS ([Round 7: 76.3% vs 71.2%] to [Round 11: 68.5% vs 76.4%]). Both algorithms identified participants with more severe dementia. Conclusion: Claims-based dementia algorithms demonstrate broadly consistent performance in MA and FFS populations, with high specificity and moderate PPV but comparable or lower sensitivity in MA, informing case ascertainment across Medicare plan type.Keywords
Funding Information
- National Institutes of Health (R56AG084578)
- National Institutes of Health
This publication has 33 references indexed in Scilit:
- Studying Medicare Advantage With Existing Data—Pitfalls, Challenges, and OpportunitiesJAMA Network Open, 2025
- Evaluating linked ICD‐10 Medicare claims data as a method of dementia case ascertainment in research settingsAlzheimer's & Dementia, 2025
- Co-calibration of cognitive performance in the National Health and Aging Trends Study with the Health and Retirement Study's Harmonized Cognitive Assessment Protocol: Implications for dementia classificationSSM - Population Health, 2025
- Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for primary careAlzheimer's & Dementia, 2024
- Validation of Claims-Based Frailty Index for Identifying Moderate-to-Severe Dementia in Medicare BeneficiariesJournal of the American Medical Directors Association, 2024
- Analysis of agreement between measures of subjective cognitive impairment and probable dementia in the National Health and Aging Trends StudyAlzheimer's & Dementia, 2024
- Trends in Incident Dementia Diagnosis Before and After Medicare Risk AdjustmentJAMA Network Open, 2023
- Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare AdvantageAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
- Evaluation of Potentially Avoidable Acute Care Utilization Among Patients Insured by Medicare Advantage vs Traditional MedicareJAMA Health Forum, 2023
- Tradeoffs between accuracy measures for electronic health care data algorithmsJournal of Clinical Epidemiology, 2012